Company Edge Therapeutics Inc Nasdaq
Equities
US2798701098
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 19-03-14 |
Director of Finance/CFO | 55 | Dec. 03 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Spencer Brown
CMP | Compliance Officer | 54 | 22-05-31 |
Gregory Conn
CTO | Chief Tech/Sci/R&D Officer | 69 | 04-12-31 |
Joe J. Dervan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CHM | Chairman | 65 | 19-04-01 |
Otis Brawley
BRD | Director/Board Member | 64 | 20-11-02 |
Richard Sykes
BRD | Director/Board Member | 79 | 19-02-28 |
Director/Board Member | 65 | 20-02-20 | |
Gregory Freitag
BRD | Director/Board Member | 62 | 19-02-28 |
Frank Bedu-Addo
FOU | Founder | 59 | 19-03-14 |
Ilian Iliev
BRD | Director/Board Member | 48 | 20-04-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,679,275 | 35,333,177 ( 96.33 %) | 0 | 96.33 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.40% | 103B | |
+1.87% | 95.28B | |
+1.46% | 22.15B | |
-15.75% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.31% | 16.05B | |
+4.84% | 13.68B | |
+35.63% | 12.17B |